Loading clinical trials...
Loading clinical trials...
This study is being done to evaluate the efficacy and safety of asenapine as compared to placebo in preventing the recurrence of mood episodes after stabilization of an acute/manic mixed episode in pa...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Forest Laboratories
NCT06740383 · Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia, and more
NCT04580134 · Schizophrenia, Schizoaffective Disorder, and more
NCT07185815 · Major Depressive Disorder (MDD), Bipolar 1 Disorder, and more
NCT07314190 · Alzheimer Disease, Dementia With Lewy Bodies (DLB), and more
NCT00764478 · Bipolar 1 Disorder
Forest Investigative Site 3017
Anaheim, California
Forest Investigative Site 3019
Chino, California
Forest Investigative Site 3001
Escondido, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions